These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8849761)

  • 21. Slipping through the bowel cancer screening programme.
    Hallifax R; Lacey M; Bevis P; Borley NR; Brooklyn T; Wheeler JM
    Colorectal Dis; 2012 Jul; 14(7):844-7. PubMed ID: 21920009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients.
    Kaul A; Shah A; Magill FH; Hawkins SA; Skaife P
    Int J Surg; 2013; 11(4):329-31. PubMed ID: 23459187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: A population-based study.
    James PD; Rabeneck L; Yun L; Paszat L; Baxter NN; Govindarajan A; Antonova L; Tinmouth JM
    J Med Screen; 2018 Sep; 25(3):141-148. PubMed ID: 28862521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for colorectal cancer using an immunochemical test for faecal occult blood: results of the first 2 years of a South Australian programme.
    Weller D; Thomas D; Hiller J; Woodward A; Edwards J
    Aust N Z J Surg; 1994 Jul; 64(7):464-9. PubMed ID: 8010915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence.
    Ventura L; Mantellini P; Grazzini G; Castiglione G; Buzzoni C; Rubeca T; Sacchettini C; Paci E; Zappa M
    Dig Liver Dis; 2014 Jan; 46(1):82-6. PubMed ID: 24011791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
    Yamamoto M; Nakama H
    Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening: yield of faecal occult blood testing.
    Teoh ML; Puvan R; Cheah PY; Yuen Y
    Asian Pac J Cancer Prev; 2010; 11(1):153-6. PubMed ID: 20593948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
    UK Colorectal Cancer Screening Pilot Group
    BMJ; 2004 Jul; 329(7458):133. PubMed ID: 15237087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
    Robinson MH; Marks CG; Farrands PA; Bostock K; Hardcastle JD
    Br J Surg; 1996 Apr; 83(4):500-1. PubMed ID: 8665240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harms of colonoscopy in a colorectal cancer screening programme with faecal occult blood test: a population-based cohort study.
    Denis B; Gendre I; Sauleau EA; Lacroute J; Perrin P
    Dig Liver Dis; 2013 Jun; 45(6):474-80. PubMed ID: 23414583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler B; Irwig L; Glasziou P; Kewenter J; Weller D; Silagy C
    BMJ; 1998 Aug; 317(7158):559-65. PubMed ID: 9721111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.